Casey graduated with a Masters in Biochemistry from the University of Maryland, College Park. He has spent more than 15 years in senior leadership roles in the intellectual property services industry. As Co-Founder of BioMEMS Diagnostics, he plays a pivotal role in our commercialization efforts and driving growth into the various markets.
Mike has spent 30 years in the biomedical, in-vitro diagnostic industry where he contributed to more than 20 new product launches for Bayer and Siemens. He spent 15 years as a director of research and development working on next generation analytical and diagnostic technologies in collaboration with leading institutions and companies. In 2009, Pugia was awarded the Siemens Inventor of the Year for his work on a miniaturized “lab-on-a-chip” diagnostic tool. Before joining BioMEMS Diagnostics, Mike co-founded the Indiana Biosciences Research Institute (IBRI) serving 5+ years as the Director of the Bioanalytical Technologies Group. He holds 60 U.S. patents and has 70 active U.S. patent applications with more than 500 worldwide patent filings.
Jacob graduated in 2019 from Bethel University and the University of Notre Dame with degrees in Math/Physics and Electrical Engineering, respectively. Since then, he has worked as a research and design engineer with Indiana Integrated Circuits where he has worked on PCB design, assembly, controller programming, and IC design and fabrication.
Mike graduated from San Jose State University in 1998 and 2001, with Bachelors and Masters in Mechanical Engineering. Since then, he has worked within many different technologies as a Lead Engineer, Individual Contributor, Staff and Consultant roles at companies such as Apple on Cameras for iPhones, L3 for space telescopes JWST (just launched!) and many biotech companies like Thermofisher, Applied Biosystems, Life Technologies, and Fluidigm working on PCR analyzer instrumentation.
Dr. Baird received a Ph. D. in analytical chemistry from Purdue University in 2015, focused on mass spectrometry instrument design and application. He spent the next four years working on the design and development of a highly sensitive immunoassay platform as part of teams at both Siemens and the Indiana Biosciences Research Institute (IBRI). Since 2019 he has held roles at Baxter BioPharma Solutions (BPS) where he specialized in analytical method development and validation as well as the design and optimization of lyophilization processes for biologics and small molecules. Zane has 3+ years of cGMP/GLP experience, expertise in a wide array of analytical technologies, and over 40 patents and publications.